Objective-Recent studies of bone marrow (BM)-transplanted apoE knockout (apoE Ϫ/Ϫ ) mice have concluded that a substantial fraction of smooth muscle cells (SMCs) in atherosclerosis arise from circulating progenitor cells of hematopoietic origin. This pathway, however, remains controversial. In the present study, we reexamined the origin of plaque SMCs in apoE Ϫ/Ϫ mice by a series of BM transplantations and in a novel model of atherosclerosis induced in surgically transferred arterial segments. Methods and Results-We analyzed plaques in lethally irradiated apoE Ϫ/Ϫ mice reconstituted with sex-mismatched BM cells from eGFP ϩ apoE Ϫ/Ϫ mice, which ubiquitously express enhanced green fluorescent protein (eGFP), but did not find a single SMC of donor BM origin among Ϸ10 000 SMC profiles analyzed. We then transplanted arterial segments between eGFP ϩ apoE Ϫ/Ϫ and apoE Ϫ/Ϫ mice (isotransplantation except for the eGFP transgene) and induced atherosclerosis focally within the graft by a recently invented collar technique. No eGFP ϩ SMCs were found in plaques that developed in apoE Ϫ/Ϫ artery segments grafted into eGFP ϩ apoE Ϫ/Ϫ mice. Concordantly, 96% of SMCs were eGFP ϩ in plaques induced in eGFP ϩ apoE Ϫ/Ϫ artery segments grafted into apoE Ϫ/Ϫ mice.
R ecruitment of smooth muscle cells (SMCs) is a key mechanism in the development of atherosclerosis and its clinical manifestations. SMCs contribute to plaque volume through matrix synthesis, and the accretion of SMCs plays a decisive role in the pathogenesis of coronary stenosis. 1 Conversely, paucity of SMCs in the fibrous cap of plaques increases the risk of plaque rupture and life-threatening arterial thrombosis. 2 Understanding the origin of plaque SMCs may provide new opportunities for controlling their ambiguous nature.
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Until recently, the only source of SMCs in atherosclerotic lesions was considered to be the local vessel wall. According to this hypothesis, local SMCs in the arterial media and intima modulate into a synthetic and migratory phenotype (aka, phenotypic modulation 3 ) and form the fibrous component of the plaque. This theory was essentially inferred from a line of suggestive observations in arterial injury models in the 70s and 80s. 4, 5 More to the point, Cre/lox fate mapping in the apoE knockout (apoE Ϫ/Ϫ ) mouse model of atherosclerosis recently confirmed that preexisting SMCs, presumably from the local media, contribute to plaque SMCs during atherogenesis, but the existence of other sources could not be excluded by this technique. 6 In 2002, an alternative and major source of SMCs in atherosclerosis was reported, 7 and this new paradigm has great impact on current research in this area. 8, 9 Based on observations in bone marrow (BM)-transplanted apoE Ϫ/Ϫ mice, it was concluded that a substantial fraction of plaque SMCs arise from circulating progenitor cells of hematopoietic origin. 7 This pathway holds promise for the development of novel therapeutic means of controlling the recruitment and accumulation of SMCs in plaques. However, it remains questionable whether the quality of the histological documentation in that study can support a definitive conclusion, especially because the seeming use of unfixed tissue for detection of enhanced green fluorescent protein (eGFP) can lead to diffusion of the tracer marker from sectioned cells. 10 Furthermore, reconstitution of apoE Ϫ/Ϫ mice with apoE ϩ/ϩ BM as performed in that experiment provides powerful protection against the development of atherosclerosis. 11 To address these concerns, we repeated the BM transplantation experiment in apoE Ϫ/Ϫ mice with a number of methodological modifications but could not replicate the results. To confirm and extend these findings, we then studied atherosclerosis induced in surgically transferred arterial segments. Here, we show that atherosclerotic plaque SMCs are derived from the local vessel wall and not circulating smooth muscle progenitor cells in apoE Ϫ/Ϫ mice.
Methods
For a detailed Methods section, please see the online data supplement, available online at http://atvb.ahajournals.org.
Transgenic Animals
The Danish Animal Experiments Inspectorate approved all procedures. ApoE Ϫ/Ϫ mice (B6.129P2-Apoe tm1Unc ; Taconic M&B, Ry, Denmark), backcrossed more than 10 times to C57BL/6 mice, and eGFP ϩ C57BL/6 mice (C57BL/6-Tg[ACTB-EGFP]1Osb/J; Jackson Laboratories, Bar Harbor, Me), were intercrossed to obtain eGFP ϩ apoE Ϫ/Ϫ mice (hemizygous for the eGFP transgene).
Bone Marrow Transplants
ApoE Ϫ/Ϫ mice (nϭ28) were lethally irradiated and rescued with sex-matched bone marrow from eGFP ϩ apoE Ϫ/Ϫ mice as previously described (Figure 1a ). 12 Age-matched apoE Ϫ/Ϫ (nϭ8) and eGFP ϩ apoE Ϫ/Ϫ mice (nϭ8) were included as controls. One mouse died shortly after BM transplantation. Four randomly-chosen BMtransplanted mice were killed after 4 weeks. The other mice were changed from chow to high fat diet (21% saturated fat, 1.5% cholesterol, Hope Farms, Woerden, Netherlands) to accelerate atherogenesis and then killed at 20 or 32 weeks of age.
Atherosclerosis Induced in Transplanted Arterial Segments
We performed orthotopic transplantations of common carotid artery (CCA) segments between eGFP ϩ apoE Ϫ/Ϫ and apoE Ϫ/Ϫ mice (eGFP ϩ apoE Ϫ/Ϫ CCA 3 apoE Ϫ/Ϫ transplanted mice, nϭ12, and apoE Ϫ/Ϫ CCA 3 eGFP ϩ apoE Ϫ/Ϫ transplanted mice, nϭ12, excluding perioperative deaths). Transplantations were isogenic apart from the eGFP transgene and immunogenicity of eGFP has been reported to be minimal in the background C57BL/6 strain. 13 All grafted vessels were patent after 6 weeks. Then, localized atherosclerosis was induced by placement of a constrictive perivascular collar around the distal part of the graft using a technique slightly modified from von der Thüsen et al (nϭ10 from each group) ( Figure 1b ). 14 Four mice (eGFP ϩ apoE Ϫ/Ϫ CCA 3 apoE Ϫ/Ϫ transplanted mice, nϭ2, and apoE Ϫ/Ϫ CCA 3 eGFP ϩ apoE Ϫ/Ϫ transplanted mice, nϭ2) were treated identically with the exception that no collars were inserted.
Immunohistochemistry
SMCs were identified by staining for smooth muscle ␣-actin (SM␣A). This abundant protein is considered the most sensitive, though not specific, SMC marker. SM␣A is expressed early in embryonic development 15 and lost late in phenotypic modulation, 3 and it is the marker on which previous conclusions on BM origin of plaque SMCs have been based. 7, 16 Specificity of SM␣A stainings was confirmed by observing the expected subplasmalemmal distribution of SM␣A in plaque SMCs and by negative isotype control stainings. The Mac2 epitope was used as a marker for plaque macrophages.
Fluorescence In Situ Hybridization
The Y chromosome was visualized in a subset of SM␣A stained aortic root sections. First, z-axis image stacks of SM␣A ϩ cellcontaining areas were acquired and stored. Then, cover slips were removed and the immunostained sections were pretreated in 10 mmol/L sodium citrate, pH 6.0 (2 hours, 80°C) and 0.025% pepsin solution (10 minutes, 37°C; Sigma), which totally extinguished eGFP fluorescence and deteriorated the SM␣A staining signal. Y chromosomes were then detected by a fluorescein isothiocyanate (FITC)-conjugated paint probe using the protocol recommended by the manufacturer (Cambio), and the phenotype of cells with Y ϩ nuclei was identified in the stored images. This sequential technique allows for a robust analysis, because the cell phenotype is analyzed before the harsh pretreatment necessary for fluorescence in situ hybridization (FISH) distorts morphology.
Microscopic Analysis
Sections were examined in an Olympus Cell-R epifluorescence microscope system equipped with differential interference contrast (DIC) optics and motorized focus. Deconvolution analysis on widefield z-axis image stacks (0.3 m optical thickness) was performed in a subset of sections (aortic root sections for sequential FISH analysis and CCA plaques) by using a blind 3D deconvolution algorithm (Autoquant Deblur 9.3; Autoquant Imaging). This tech- nique, like confocal microscopy, yields high signal-to-noise images of thin optical sections.
SM␣A ϩ cell profiles in the range of small SMC nuclei or larger (from Ϸ3 m [minor axis] ϫ 5 m [major axis]) were analyzed for colocalization. Because all SMCs contain a nucleus of relatively similar size, this strategy is an accurate analysis of the presence of eGFP ϩ SM␣A ϩ cells and avoids many interpretational problems presented by smaller autofluorescent structures and overlapping parts of closely opposed eGFP ϩ and SM␣A ϩ cells. The number of analyzed SM␣A profiles was counted to estimate statistical power. In BM transplanted mice, we estimated the total number by counting a representative subset (34%) of the sections. Nucleated SM␣A ϩ profiles, defined as cells where the nucleus were circumscribed by SM␣A ϩ stain, were counted and analyzed for combined Y chromosome and SM␣A signal.
Statistical Analysis
Rare binomially distributed events approach the Poisson distribution, and a 95% confidence limit for double-positive cells were calculated by this approximation (95% confidence limit: PϽ3.0/number of observations). Sections were taken at least 50 m apart to ensure that the same SMC was not analyzed twice.
Results

Sex-Mismatched BM Transplantation
The degree of hematopoietic chimerism obtained in eGFP ϩ apoE Ϫ/Ϫ BM 3 apoE Ϫ/Ϫ transplanted mice was assessed by flow cytometry of peripheral blood leukocytes. The fraction of fluorescent cells in BM transplanted mice 4 and 24 weeks after transplantation was 93.4Ϯ2.8% (meanϮSD, nϭ23) and 93.7Ϯ1.4% (nϭ12), respectively, which was similar to that of eGFP ϩ apoE Ϫ/Ϫ positive control mice (92.4Ϯ2.0% [nϭ4] and 92.2Ϯ0.8% [nϭ4], respectively; Figure 2a ). The sustained presence of eGFP ϩ leukocytes documents the replacement of hematopoietic stem cells, which are the only long-term self-renewing cells in the hematopoietic system. 17 Plasma lipid values are described in supplemental Table I .
Vascular Pathology in BM Chimeras
In animals euthanized 4 weeks after BM transplantation (nϭ4), only foam cell lesions were present at the arterial sites selected for analysis, excluding the possibility that SMCs had entered the intima already before full reconstitution of the hematopoietic system with eGFP ϩ cells was confirmed. At 20 weeks of age, all mice had developed fibrofatty plaques in the aortic root, and fibrofatty plaques were also present in the aortic arch, brachiocephalic trunk, abdominal aorta, and to a variable extent in the descending thoracic aorta at 32 weeks of age.
Atherosclerotic Plaque SMCs Are Not Derived From Hematopoietic Stem Cells
As an internal validation of the experiment, the hematopoietic origin of plaque macrophages was verified by the demonstration of cells double-positive for eGFP and the murine macrophage marker Mac2 in plaques in BM transplanted mice (Figure 2b ).
SM␣A ϩ cells were predominantly located in the fibrous cap separating the core of the plaque from the arterial lumen. As expected, SM␣A ϩ cells were almost uniformly eGFP ϩ in eGFP ϩ apoE Ϫ/Ϫ positive control mice (nϭ4, 32 weeks of age, 580 of 598 SM␣A ϩ cell profiles analyzed). In agreement with observations reported by others, SM␣A expression was lost in major parts of the media underlying atherosclerotic plaques (Figure 3 ). 7 We did not identify a single eGFP ϩ SM␣A ϩ cell among Ϸ10 000 SM␣A ϩ cell profiles analyzed in 154 sections from multiple sites of the arterial tree in 23 BM-transplanted mice (95% confidence limit Ͻ0.03%) (Figures 1a and Figure 3 ; supplemental Figure I ). The identical result was reached using blind 3D deconvolution performed on a subset of the same sections from the aortic root ( Figure 4) .
As an independent tracing method, we detected Y chromosomes in SM␣A immunostained sections from the aortic root (Figure 4 ). Not once did we convincingly detect a Y chromosome in 367 analyzed nucleated SM␣A ϩ profiles in plaques from male-to-female BM-transplanted mice. In one inconclusive case, a SM␣A ϩ profile circumscribed two nuclear profiles, one of which was Y chromosome ϩ . A positive Y chromosome signal was detected in 114 of 209 analyzed nucleated SM␣A ϩ cell profiles (54%) in female-to-male BM-transplanted mice, which was similar to that detected in 
SMCs Are Derived From the Local Vessel Wall in Cross-Grafted Arterial Segments
Our observations in BM-transplanted mice showed that differentiation of hematopoietic stem cells to plaque SMCs is exceedingly rare if it occurs at all. To evaluate whether circulating smooth muscle progenitor cells of nonhematopoietic origin can contribute to atherosclerotic plaque SMCs, we then analyzed SMC origin in atherosclerotic lesions that were induced proximal to a constrictive collar in cross-grafted CCA segments (Figures 1b and 5a ).
Of 20 mice in which we performed CCA segment transplantations and collar placements, complete or near-complete graft occlusions were present in 5 mice at time of sacrifice. In 4 mice, no significant lesions were found, and in 2 mice, extensive lesion formation extending into the graft from the proximal anastomosis was present. These were all excluded from the analysis. Most likely, the cause of these technical failures was inconsistency in tightening of the ligature around the collar to yield appropriate constriction. None of the CCA-transplanted mice in which no collar was placed developed lesions in the grafted artery apart from a small mural thrombus in one.
In all other mice, advanced plaques had developed focally immediately proximal to the constrictive collar with an area of unaffected vessel wall separating the lesion from the proximal anastomosis site (Figure 5b ). In plaques that had formed in apoE Ϫ/Ϫ artery segments grafted into eGFP ϩ apoE Ϫ/Ϫ mice (nϭ4), not a single eGFP ϩ SM␣A ϩ cell 
Bentzon et al
Origin of SMCs in Atherosclerosis in ApoE ؊/؊ Mice was detected in 54 serial sections (10 to 16 per plaque), encompassing 684 SMC profiles (95% confidence limit, Ͻ0.4%; Figure 6a through 6c). Concordantly, in plaques induced in eGFP ϩ apoE Ϫ/Ϫ artery segments grafted into apoE Ϫ/Ϫ recipients (nϭ5), nearly all SM␣A ϩ cells were eGFP ϩ (Figure 6d through 6f ). We analyzed 34 sections from this type of lesion (6 to 9 per plaque) and found that 469 of 487 (96%) SMC profiles were clearly eGFP ϩ , which was similar to that seen in plaques from positive control eGFP ϩ apoE Ϫ/Ϫ mice.
Discussion
In this study, we traced the origin of plaque SMCs in different models of atherosclerosis in the apoE Ϫ/Ϫ hyperlipidemic mouse. First, we attempted and failed to reproduce the previous finding that hematopoietic stem cells can contribute to plaque SMCs in BM chimeric apoE Ϫ/Ϫ mice. 7 Second, we directly evaluated and confirmed that plaque SMCs are derived from cells of the local vessel wall in a novel model of collar-induced atherosclerosis in surgically transferred artery segments.
Induction of Atherosclerosis in Surgically Transferred CCA Segments
An important premise for basing our conclusions on the collar-induced atherosclerosis model is that the pathogenesis is equivalent to that of spontaneously developing atherosclerosis. An extensive number of observations support this assumption. Lesions in the constrictive collar model develop immediately proximal to the collar, presumably elicited by low wall shear stress in this region, 18 and are strictly dependent on the presence of hypercholesterolemia. 14 Thus, lesion development in this model appears to depend on the two key etiologic factors known for spontaneous atherosclerosis. These features distinguish the constrictive collar model fundamentally from any other mechanical means of inducing intimal lesions, including the classic loose cuff model of neointima formation. 19 Furthermore, constrictive collarinduced lesions are pathoanatomically reminiscent of spontaneously developing atherosclerosis with respect to the presence of macrophage foam cells (supplemental Figure II) , cholesterol crystals, fibrous caps, and necrotic cores ( Figure  6d ). It can never be proved that constrictive collar-induced and spontaneous atherosclerosis are identical pathological entities, but it seems unlikely that disease processes that resemble each other to such detail in etiology and morphology would differ in a key mechanism such as SMC recruitment.
Origin of SMCs in Different Vascular Disease Models
The present study is only one of several recent studies to have (re)investigated the origin of lesional SMCs in arterial disease, and not the first to have reached a conclusion that conflicts with others. Surprisingly few groups have examined the most prevalent arterial disease, atherosclerosis, 7,16 but analogous investigations have been carried out in a number of other vascular disease models. 8, 9 The major discussion stemming from these studies has been over the question whether lesional SMCs can originate from BM cells. Besides the report of Sata et al on atherosclerosis in apoE Ϫ/Ϫ mice, 7 this has been described to occur in human atherosclerosis, 16 and in rodent models of wire injury, 7,20 ferric chloride injury, 21 and allotransplantation arteriopathy. 7, 22 Others, however, have not been able to detect BM-derived SMCs in allotransplantation arteriopathy, 12 and it has been reported not to be involved in the pathogenesis of vein graft atherosclerosis, 23 ligation-induced neointima, 19 and neointima formed within a loose cuff. 19 It is conceivable that part of the disparity in these findings, including the conflict between our results and those of Sata et al, 7 is attributable to methodological or interpretational differences. For instance, it is strikingly difficult, despite a considerable literature, to find compelling images of BMderived SM␣A ϩ cells with the expected SMC morphology. But it is also reasonable to think that biological differences between models are important. Even though intimal SMC accumulation is the common hallmark of many types of vascular disease, the etiology and pathogenesis of lesion development differ. Interestingly, recruitment of circulating smooth muscle progenitor cells has predominantly been reported in models with significant endothelial disruption and platelet deposition, and experimental evidence indicates that SDF␣ expressed by adhering platelets facilitates homing of circulating progenitor cells. 24 This hypothesis offers a possible explanation for the discrepancy between our results and those reported for coronary atherosclerosis in sexmismatched BM transplanted patients. 16 It is possible that asymptomatic plaque rupture with mural thrombus in humans, which is not seen in the mouse model, is critical in mediating homing of circulating progenitor cells. The finding of intimal SMCs that do not originate from the graft or from hematopoietic stem cells in rodent models of vein graft atherosclerosis and allotransplantation arteriopathy has led to the theory that circulating smooth muscle progenitor cells of nonhematopoietic origin exist and participate in vascular lesion formation. 25 It is, however, important to realize that migration of SMCs from the contiguous vasculature into the graft in those types of studies has not been conclusively excluded. For instance, Hu et al found that 40% of SMCs in atherosclerotic lesions of vein grafts were not derived from the local vessel wall or from hematopoietic stem cells, but the experimental design did not allow to distinguish between SMCs migrating through the anastomosis sites and homing and differentiation of SMCs from nonhematopoietic circulating progenitor cells. 23 If migrating medial SMCs were the source of these cells, then the fact that our lesions developed isolated from the recipient vasculature by a stretch of unaffected donor vessel (Figure 6a ), whereas lesions in the vein graft model did not, may explain the differences in the result obtained. Another explanation could be the inherent differences between SMCs of arterial and venous origin. 26 
Local Source of Plaque SMCs
Our experiments were not designed to discriminate between candidate sources for plaque SMCs within the vascular wall.
Several alternatives to vascular SMCs have been proposed, including endothelial-to-SMC differentiation and invasion of fibroblasts or stem cell progeny from the tunica adventitia. 27, 28 However, the identification of the local arterial wall as the origin of plaque SMCs established in this study combined with the observation of Feil et al that a major fraction of plaque SMCs originate from SM22␣ ϩ cells, 6 pinpoint that in mice-that have no resident intimal SMCs-tunica media is the major contributor to SMCs in atherosclerotic plaques.
Conclusions
Our experiments demonstrate that atherosclerotic plaque SMCs are derived exclusively from the local vessel wall in apoE Ϫ/Ϫ mice. This observation strongly supports the original hypothesis that these cells originate from local vascular SMCs and disagrees with the proposed role of circulating smooth muscle progenitor cells in atherogenesis. These findings have implications for future research into the mechanisms by which the fibrous component of atherosclerosis develops.
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